A 24 month, randomized, controlled, study to evaluate

Project: Research project

Description

A 24 month, randomized, controlled, study to evaluate the efficacy and safety of concentrationcontrolled everolimus plus reduced tacrolimus compared to standard tacrolimus in recipients of living donor liver transplants
StatusFinished
Effective start/end date4/1/142/15/19

Funding

  • NOVARTIS PHARMACEUTICALS CORPORATION

Fingerprint

Living Donors
Tacrolimus
Transplants
Safety
Liver
Everolimus